Clinical Trials Logo

Filter by:
NCT ID: NCT00687180 Completed - Clinical trials for Autoimmune Hepatitis

Mycophenolate vs Azathioprin in Autoimmune Hepatitis

Start date: n/a
Phase: Phase 4
Study type: Interventional

A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.

NCT ID: NCT00686569 Completed - Esophageal Cancer Clinical Trials

Mediastinal Microdialysis in Patients With Oesophageal or Cardia Cancer Treated by Resection

Start date: April 2007
Phase: N/A
Study type: Observational

Postoperative anastomotic leakage is a serious complication in patients with oesophageal or cardia cancer. Early diagnosis and treatment are mandatory. The primary aim of the present study is to investigate the clinical use of mediastinal microdialysis and whether is able to detect anastomotic leakage prior to the development of clinical symptoms.

NCT ID: NCT00685464 Completed - Atherosclerosis Clinical Trials

Intravenous Versus Intracoronary Use of Abciximab

Start date: January 2006
Phase: N/A
Study type: Interventional

The aim of this study is to investigate wether intracoronary use of bolus Abciximab is superior to intravenous bolus in patients undergoing percutaneous coronary intervention.

NCT ID: NCT00683865 Completed - Clinical trials for Pelvic Inflammatory Disease

Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.

MAIDEN
Start date: April 2003
Phase: Phase 3
Study type: Interventional

Comparison of various antibiotics in treatment of uncomplicated pelvic inflammatory disease

NCT ID: NCT00683176 Completed - Clinical trials for Diabetic Macular Edema

Effect of Choline Fenofibrate (SLV348) on Macular Edema

Start date: September 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effect of choline fenofibrate on the regression of macular edema in eyes of subjects with type 2 diabetes mellitus (T2DM) presenting with diabetic macular edema (DME)

NCT ID: NCT00681941 Completed - Clinical trials for Chronic Kidney Disease

An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis

Start date: January 2006
Phase: Phase 3
Study type: Interventional

Approximately 45 hyperphosphatemic CKD patients not on dialysis will be entered into this study at approximately 20 sites within Europe and 5-10 in Australia. The purpose of this study is to determine if sevelamer carbonate tablets dosed three times a day (TID) is an effective treatment for the control of serum phosphorous levels in hyperphosphatemic CKD patients not on dialysis. Total length of participation is approximately 14 weeks.

NCT ID: NCT00681187 Completed - Clinical trials for Neuroendocrine Tumour With Carcinoid Symptoms

Somatuline Autogel Preference and Health Economy Study

SAPHE
Start date: June 2008
Phase: Phase 4
Study type: Interventional

The primary aim of this study is to assess which method of lanreotide Autogel administration patients with neuroendocrine tumours prefer - self/partner administrations or healthcare provided administrations. The study will also assess if self/partner administration can be performed without loss of efficacy and with a preserved safety profile. The impact of self/partner administration on resource utilisation and costs will be studied. In addition, we will also assess the healthcare provider's experience of the two administration practices.

NCT ID: NCT00680186 Completed - Thromboembolism Clinical Trials

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

RE-COVER II
Start date: April 2008
Phase: Phase 3
Study type: Interventional

The general aim of this study is to determine the comparative safety and efficacy of dabigatran etexilate 150 mg bid administered orally and warfarin Pro re nata (As needed/PRN) to maintain an International Normalised Ratio (INR) of 2.0-3.0 for 6 month treatment of acute symptomatic VTE. The primary objective is to investigate the efficacy of dabigatran compared to warfarin during the 6 month treatment period. The investigation of other selected efficacy aspects and safety are regarded as secondary objective of this trial.

NCT ID: NCT00679731 Completed - Psoriasis Clinical Trials

A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Start date: April 2008
Phase: Phase 3
Study type: Interventional

This study is being conducted to compare the efficacy of ABT-874 versus Methotrexate in subjects with moderate to severe plaque psoriasis.

NCT ID: NCT00679588 Completed - Clinical trials for Venous Thromboembolism

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

SAVE-ABDO
Start date: April 2008
Phase: Phase 3
Study type: Interventional

The primary objective is to compare the efficacy and safety of once daily (q.d.) subcutaneous (s.c.) injections of Semuloparin sodium (AVE5026) with q.d. s.c. injections of Enoxaparin for the prevention of Venous Thromboembolic Events (VTE) in patients undergoing major abdominal surgery. The secondary objectives are to evaluate the safety of Semuloparin sodium (AVE5026) and to document Semuloparin sodium (AVE5026) exposure in this population.